Cargando…
Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
AIMS: We sought to conduct a meta-analysis to evaluate the efficacy and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with heart failure (HF) with preserved ejection fraction (HFpEF) and HF with mildly reduced ejection fraction (HFmrEF). METHODS: We searched the Cochrane L...
Autores principales: | Cheema, Huzaifa Ahmad, Shafiee, Arman, Athar, Mohammad Mobin Teymouri, Rafiei, Mohammad Ali, Mehmannavaz, Atefe, Jafarabady, Kyana, Shahid, Abia, Ahmad, Adeel, Ijaz, Sardar Hassan, Dani, Sourbha S., Minhas, Abdul Mannan Khan, Nashwan, Abdulqadir J., Fudim, Marat, Fonarow, Gregg C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602781/ https://www.ncbi.nlm.nih.gov/pubmed/37900570 http://dx.doi.org/10.3389/fcvm.2023.1273781 |
Ejemplares similares
-
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
por: Shafiee, Arman, et al.
Publicado: (2022) -
Higher versus lower blood pressure targets after cardiac arrest: A meta-analysis of randomized controlled trials
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2023) -
No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022) -
Advancing surgical setting: A paradigm for healthcare workers during the monkeypox outbreak
por: Teymouri Athar, Mohammad Mobin, et al.
Publicado: (2022) -
A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?
por: Shafiee, Arman, et al.
Publicado: (2023)